Suppr超能文献

非编码RNA:癌症和炎症性疾病中新兴的生物标志物及治疗靶点

Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases.

作者信息

Hossam Abdelmonem Basma, Kamal Lereen T, Wardy Lilian Waheed, Ragheb Manon, Hanna Mireille M, Elsharkawy Mohamed, Abdelnaser Anwar

机构信息

Institute of Global Health and Human Ecology, School of Sciences and Engineering, The American University in Cairo, New Cairo, Egypt.

Basic Sciences Department, Faculty of Physical Therapy, October University for Modern Sciences and Arts (MSA), Giza, Egypt.

出版信息

Front Oncol. 2025 Mar 10;15:1534862. doi: 10.3389/fonc.2025.1534862. eCollection 2025.

Abstract

Non-coding RNAs (ncRNAs) have a significant role in gene regulation, especially in cancer and inflammatory diseases. ncRNAs, such as microRNA, long non-coding RNAs, and circular RNAs, alter the transcriptional, post-transcriptional, and epigenetic gene expression levels. These molecules act as biomarkers and possible therapeutic targets because aberrant ncRNA expression has been directly connected to tumor progression, metastasis, and response to therapy in cancer research. ncRNAs' interactions with multiple cellular pathways, including MAPK, Wnt, and PI3K/AKT/mTOR, impact cellular processes like proliferation, apoptosis, and immune responses. The potential of RNA-based therapeutics, such as anti-microRNA and microRNA mimics, to restore normal gene expression is being actively studied. Additionally, the tissue-specific expression patterns of ncRNAs offer unique opportunities for targeted therapy. Specificity, stability, and immune responses are obstacles to the therapeutic use of ncRNAs; however, novel strategies, such as modified oligonucleotides and targeted delivery systems, are being developed. ncRNA profiling may result in more individualized and successful treatments as precision medicine advances, improving patient outcomes and creating early diagnosis and monitoring opportunities. The current review aims to investigate the roles of ncRNAs as potential biomarkers and therapeutic targets in cancer and inflammatory diseases, focusing on their mechanisms in gene regulation and their implications for non-invasive diagnostics and targeted therapies. A comprehensive literature review was conducted using PubMed and Google Scholar, focusing on research published between 2014 and 2025. Studies were selected based on rigorous inclusion criteria, including peer-reviewed status and relevance to ncRNA roles in cancer and inflammatory diseases. Non-English, non-peer-reviewed, and inconclusive studies were excluded. This approach ensures that the findings presented are based on high-quality and relevant sources.

摘要

非编码RNA(ncRNAs)在基因调控中发挥着重要作用,尤其是在癌症和炎症性疾病中。ncRNAs,如微小RNA、长链非编码RNA和环状RNA,会改变转录、转录后和表观遗传基因表达水平。这些分子可作为生物标志物和潜在的治疗靶点,因为在癌症研究中,ncRNA表达异常已直接与肿瘤进展、转移及对治疗的反应相关联。ncRNAs与多种细胞通路相互作用,包括丝裂原活化蛋白激酶(MAPK)、Wnt和磷脂酰肌醇-3激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白(PI3K/AKT/mTOR),影响细胞增殖、凋亡和免疫反应等细胞过程。基于RNA的治疗方法,如抗微小RNA和微小RNA模拟物,恢复正常基因表达的潜力正在积极研究中。此外,ncRNAs的组织特异性表达模式为靶向治疗提供了独特机会。特异性、稳定性和免疫反应是ncRNAs治疗应用的障碍;然而,正在开发新的策略,如修饰的寡核苷酸和靶向递送系统。随着精准医学的发展,ncRNA谱分析可能会带来更个性化、更成功的治疗,改善患者预后,并创造早期诊断和监测机会。本综述旨在探讨ncRNAs作为癌症和炎症性疾病中潜在生物标志物和治疗靶点的作用,重点关注其在基因调控中的机制及其对非侵入性诊断和靶向治疗的意义。使用PubMed和谷歌学术进行了全面的文献综述,重点关注2014年至2025年发表的研究。根据严格的纳入标准选择研究,包括同行评审状态以及与ncRNAs在癌症和炎症性疾病中的作用的相关性。排除非英文、非同行评审和无定论的研究。这种方法确保所呈现的研究结果基于高质量和相关的来源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e145/11931079/b42745252b0d/fonc-15-1534862-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验